Moderna inventory slides 14% premarket after revenue and income fall wanting estimates and biotech…
Moderna Inc. shares
MRNA,
-3.88%
slid 14% in premarket commerce Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and stated short-term provide constraints…